Bridging the gap from genetic association to functional understanding: The next generation of mouse models of multiple sclerosis

Immunological Reviews

Volumn 248, Issue 1, 2012, Pages 10-22

  Attfield, Kathrine E ^a   Dendrou, Calliope A ^b   Fugger, Lars ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Experimental autoimmune encephalomyelitis; Genome wide association studies; Human leukocyte antigen; Humanized mice; Multiple sclerosis; T cell receptor

Indexed keywords

EPITOPE;

ALLERGIC ENCEPHALOMYELITIS; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; BYSTANDER EFFECT; ENVIRONMENTAL FACTOR; FUNCTIONAL GENOMICS; GENE CASSETTE; GENE DOSAGE; GENE EXPRESSION; GENE INSERTION; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC REGULATION; GENETIC RISK; GENETIC VARIABILITY; GENOME; HLA SYSTEM; HUMAN; MOLECULAR MIMICRY; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; DISEASE MODELS, ANIMAL; ENVIRONMENT; GENETIC ASSOCIATION STUDIES; HLA ANTIGENS; HUMANS; MICE; MULTIPLE SCLEROSIS;

EID: 84862726429     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/j.1600-065X.2012.01132.x     Document Type: Article

References (106)

1. De Jager PL, et al. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat Genet 2009;41:776-782.
2. Hafler DA, et al. Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 2007;357:851-862.
3. Sawcer S, et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011;476:214-219.
4. Bahlo M, et al. Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat Genet 2009;41:824-828.
5. Shendure J, Ji HL. Next-generation DNA sequencing. Nat Biotechnol 2008;26:1135-1145.
6. Altshuler DL, et al. A map of human genome variation from population-scale sequencing. Nature 2010;467:1061-1073.
7. Bentley DR, et al. Accurate whole human genome sequencing using reversible terminator chemistry. Nature 2008;456:53-59.
8. Gregersen JW, et al. Functional epistasis on a common MHC haplotype associated with multiple sclerosis. Nature 2006;443:574-577.
9. Madsen LS, et al. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor. Nat Genet 1999;23:343-347.
10. Donnelly P. Progress and challenges in genome-wide association studies in humans. Nature 2008;456:728-731.
11. Lander ES. Initial impact of the sequencing of the human genome. Nature 2011;470:187-197.
12. Fugger L, Friese MA, Bell JI. From genes to function: the next challenge to understanding multiple sclerosis. Nat Rev Immunol 2009;9:408-417.
13. Cooper GM, Shendure J. Needles in stacks of needles: finding disease-causal variants in a wealth of genomic data. Nat Rev Genet 2011;12:628-640.
14. Oksenberg JR, Baranzini SE. Multiple sclerosis genetics-is the glass half full, or half empty? Nat Rev Neurol 2010;6:429-437.
15. Dowell RD, et al. Genotype to phenotype: a complex problem. Science 2010;328:469.
16. Lappalainen T, Montgomery SB, Nica AC, Dermitzakis ET. Epistatic Selection between Coding and Regulatory Variation in Human Evolution and Disease. Am J Hum Genet 2011;89:459-463.
17. Baker M. The changes that count. Nature 2012;482:257-262.
18. Thomas D. Gene-environment-wide association studies: emerging approaches. Nat Rev Genet 2010;11:259-272.
19. Harkiolaki M, et al. T cell-mediated autoimmune disease due to low-affinity crossreactivity to common microbial peptides. Immunity 2009;30:348-357.
20. Lang HLE, et al. A functional and structural basis for TCR cross-reactivity in multiple sclerosis. Nat Immunol 2002;3:940-943.
21. Davis MM. A prescription for human immunology. Immunity 2008;29:835-838.
22. Yednock TA, Cannon C, Fritz LC, Sanchez-Madrid F, Steinman L, Karin N. Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha-4-beta-1 integrin. Nature 1992;356:63-66.
23. Wekerle H, Flugel A, Fugger L, Schett G, Serreze D. Autoimmunity's next top models. Nat Med 2012;18:66-70.
24. Roep B, Buckner J, Sawcer S, Toes R, Zipp F. The problems and promises of research into human immunology and autoimmune disease. Nat Med 2012;18:48-53.
25. Miller SD, Karpus WJ, Davidson TS. Experimental autoimmune encephalomyelitis in the mouse. Curr Protoc Immunol 2010;88:15.1.1-15.1.20.
26. Mendel I, Kerlero de Rosbo N, Ben-Nun A. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells. Eur J Immunol 1995;25:1951-1959.
27. McRae BL, Kennedy MK, Tan LJ, Dal Canto MC, Picha KS, Miller SD. Induction of active and adoptive relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalitogenic epitope of proteolipid protein. J Neuroimmunol 1992;38:229-240.
28. Berard JL, Wolak K, Fournier S, David S. Characterization of relapsing-remitting and chronic forms of experimental autoimmune encephalomyelitis in C57BL/6 mice. Glia 2010;58:434-445.
29. Lincoln MR, et al. A predominant role for the HLA class II region in the association of the MHC region with multiple sclerosis. Nat Genet 2005;37:1108-1112.
30. Oksenberg JR, et al. Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans. Am J Hum Genet 2004;74:160-167.
31. Caillier SJ, et al. Uncoupling the roles of HLA-DRB1 and HLA-DRB5 genes in multiple sclerosis. J Immunol 2008;181:5473-5480.
32. Traugott U, Reinherz EL, Raine CS. Multiple sclerosis: distribution of T cell subsets within active chronic lesions. Science 1983;219:308-310.
33. Babbe H, et al. Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J Exp Med 2000;192:393-404.
34. Frischer JM, et al. The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain 2009;132:1175-1189.
35. Kuhlmann T, Lingfeld G, Bitsch A, Schuchardt J, Bruck W. Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time. Brain 2002;125:2202-2212.
36. Anderson AC, et al. A transgenic model of central nervous system autoimmunity mediated by CD4+ and CD8+ T and B cells. J Immunol 2012;188:2084-2092.
37. Sun D, et al. Myelin antigen-specific CD8+ T cells are encephalitogenic and produce severe disease in C57BL/6 mice. J Immunol 2001;166:7579-7587.
38. Ford ML, Evavold BD. Specificity, magnitude, and kinetics of MOG-specific CD8+ T cell responses during experimental autoimmune encephalomyelitis. Eur J Immunol 2005;35:76-85.
39. Huseby ES, Liggitt D, Brabb T, Schnabel B, Ohlen C, Goverman J. A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosis. J Exp Med 2001;194:669-676.
40. Ji Q, Perchellet A, Goverman JM. Viral infection triggers central nervous system autoimmunity via activation of CD8+ T cells expressing dual TCRs. Nat Immunol 2010;11:628-634.
41. Anderton SM, Wraith DC. Selection and fine-tuning of the autoimmune T-cell repertoire. Nat Rev Immunol 2002;2:487-498.
42. Morel L, Rudofsky UH, Longmate JA, Schiffenbauer J, Wakeland EK. Polygenic control of susceptibility to murine systemic lupus erythematosus. Immunity 1994;1:219-229.
43. Hawkes CH, Macgregor AJ. Twin studies and the heritability of MS: a conclusion. Mult Scler 2009;15:661-667.
44. Zaccone P, Cooke A. Infectious triggers protect from autoimmunity. Semin Immunol 2011;23:122-129.
45. Friese MA, et al. Opposing effects of HLA class I molecules in tuning autoreactive CD8+ T cells in multiple sclerosis. Nat Med 2008;14:1227-1235.
46. Begolka WS, et al. CD8-deficient SJL mice display enhanced susceptibility to Theiler's virus infection and increased demyelinating pathology. J Neurovirol 2001;7:409-420.
47. Jiang H, Zhang SI, Pernis B. Role of CD8+ T cells in murine experimental allergic encephalomyelitis. Science 1992;256:1213-1215.
48. Noble A, Zhao ZS, Cantor H. Suppression of immune responses by CD8 cells. II. Qa-1 on activated B cells stimulates CD8 cell suppression of T helper 2 responses. J Immunol 1998;160:566-571.
49. Varthaman A, et al. Physiological induction of regulatory Qa-1-restricted CD8+ T cells triggered by endogenous CD4+ T cell responses. PLoS ONE 2011;6:e21628.
50. Hu D, Ikizawa K, Lu L, Sanchirico ME, Shinohara ML, Cantor H. Analysis of regulatory CD8 T cells in Qa-1-deficient mice. Nat Immunol 2004;5:516-523.
51. Tigno-Aranjuez JT, Jaini R, Tuohy VK, Lehmann PV, Tary-Lehmann M. Encephalitogenicity of complete Freund's adjuvant relative to CpG is linked to induction of Th17 cells. J Immunol 2009;183:5654-5661.
52. Litzenburger T, et al. B lymphocytes producing demyelinating autoantibodies: development and function in gene-targeted transgenic mice. J Exp Med 1998;188:169-180.
53. Wahren-Herlenius M, Kuchroo VK. Gene-environment interaction in induction of autoimmunity. Semin Immunol 2011;23:65-66.
54. Sartor RB. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology 2004;126:1620-1633.
55. Wen L, et al. Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 2008;455:1109-1113.
56. Ochoa-Reparaz J, Mielcarz DW, Begum-Haque S, Kasper LH. Gut, bugs, and brain: role of commensal bacteria in the control of central nervous system disease. Ann Neurol 2011;69:240-247.
57. Peterson J, et al. The NIH Human Microbiome Project. Genome Res 2009;19:2317-2323.
58. Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 2005;122:107-118.
59. Macpherson AJ, Harris NL. Interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol 2004;4:478-485.
60. Hooper LV, Gordon JI. Commensal host-bacterial relationships in the gut. Science 2001;292:1115-1118.
61. Reeves AE, Theriot CM, Bergin IL, Huffnagle GB, Schloss PD, Young VB. The interplay between microbiome dynamics and pathogen dynamics in a murine model of Clostridium difficile Infection. Gut Microbes 2011;2:145-158.
62. Goverman J, Woods A, Larson L, Weiner LP, Hood L, Zaller DM. Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell 1993;72:551-560.
63. Berer K, et al. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature 2011;479:538-541.
64. Lee YK, Menezes JS, Umesaki Y, Mazmanian SK. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 2011;108(Suppl):4615-4622.
65. Zamvil SS, Steinman L. The T lymphocyte in experimental allergic encephalomyelitis. Annu Rev Immunol 1990;8:579-621.
66. Langrish CL, et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005;201:233-240.
67. Komiyama Y, et al. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol 2006;177:566-573.
68. Matusevicius D, et al. Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Mult Scler 1999;5:101-104.
69. Tzartos JS, et al. Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am J Pathol 2008;172:146-155.
70. Hirota K, et al. Fate mapping of IL-17-producing T cells in inflammatory responses. Nat Immunol 2011;12:255-263.
71. Veldhoen M, et al. The aryl hydrocarbon receptor links Th17-cell-mediated autoimmunity to environmental toxins. Nature 2008;453:106-109.
72. Marrie RA. Environmental risk factors in multiple sclerosis aetiology. Lancet Neurol 2004;3:709-718.
73. Oldstone MB. Molecular mimicry and autoimmune disease. Cell 1987;50:819-820.
74. Gran B, Hemmer B, Vergelli M, McFarland HF, Martin R. Molecular mimicry and multiple sclerosis: degenerate T-cell recognition and the induction of autoimmunity. Ann Neurol 1999;45:559-567.
75. Hausmann S, Martin M, Gauthier L, Wucherpfennig KW. Structural features of autoreactive TCR that determine the degree of degeneracy in peptide recognition. J Immunol 1999;162:338-344.
76. Hahn M, Nicholson MJ, Pyrdol J, Wucherpfennig KW. Unconventional topology of self peptide-major histocompatibility complex binding by a human autoimmune T cell receptor. Nat Immunol 2005;6:490-496.
77. Williams KP, et al. Phylogeny of gammaproteobacteria. J Bacteriol 2010;192:2305-2314.
78. Correale J, Fiol M, Gilmore W. The risk of relapses in multiple sclerosis during systemic infections. Neurology 2006;67:652-659.
79. Horwitz MS, Bradley LM, Harbertson J, Krahl T, Lee J, Sarvetnick N. Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry. Nat Med 1998;4:781-785.
80. Horwitz MS, Ilic A, Fine C, Rodriguez E, Sarvetnick N. Presented antigen from damaged pancreatic beta cells activates autoreactive T cells in virus-mediated autoimmune diabetes. J Clin Invest 2002;109:79-87.
81. Croxford JL, Olson JK, Miller SD. Epitope spreading and molecular mimicry as triggers of autoimmunity in the Theiler's virus-induced demyelinating disease model of multiple sclerosis. Autoimmun Rev 2002;1:251-260.
82. Lipton HL, Twaddle G, Jelachich ML. The predominant virus antigen burden is present in macrophages in Theiler's murine encephalomyelitis virus-induced demyelinating disease. J Virol 1995;69:2525-2533.
83. Pope JG, Karpus WJ, VanderLugt C, Miller SD. Flow cytometric and functional analyses of central nervous system-infiltrating cells in SJL/J mice with Theiler's virus-induced demyelinating disease. Evidence for a CD4+ T cell-mediated pathology. J Immunol 1996;156:4050-4058.
84. Katz-Levy Y, et al. Endogenous presentation of self myelin epitopes by CNS-resident APCs in Theiler's virus-infected mice. J Clin Invest 1999;104:599-610.
85. Ittner LM, Gotz J. Pronuclear injection for the production of transgenic mice. Nat Protoc 2007;2:1206-1215.
86. Smithies O, Gregg RG, Boggs SS, Koralewski MA, Kucherlapati RS. Insertion of DNA sequences into the human chromosomal beta-globin locus by homologous recombination. Nature 1985;317:230-234.
87. Capecchi MR. Altering the genome by homologous recombination. Science 1989;244:1288-1292.
88. Churchman SM, et al. A novel TNFRSF1A splice mutation associated with increased nuclear factor kappaB (NF-kappaB) transcription factor activation in patients with tumour necrosis factor receptor associated periodic syndrome (TRAPS). Ann Rheum Dis 2008;67:1589-1595.
89. Schlake T, Bode J. Use of mutated FLP recognition target (FRT) sites for the exchange of expression cassettes at defined chromosomal loci. Biochemistry 1994;33:12746-12751.
90. Sharan SK, Thomason LC, Kuznetsov SG, Court DL. Recombineering: a homologous recombination-based method of genetic engineering. Nat Protoc 2009;4:206-223.
91. Nagy A. Cre recombinase: the universal reagent for genome tailoring. Genesis 2000;26:99-109.
92. Raymond CS, Soriano P. High-efficiency FLP and PhiC31 site-specific recombination in mammalian cells. PLoS ONE 2007;2:e162.
93. Chen CM, Krohn J, Bhattacharya S, Davies B. A comparison of exogenous promoter activity at the ROSA26 locus using a PhiC31 integrase mediated cassette exchange approach in mouse ES cells. PLoS ONE 2011;6:e23376.
94. Tchorz JS, et al. A modified RMCE-compatible Rosa26 locus for the expression of transgenes from exogenous promoters. PLoS ONE 2012;7:e30011.
95. Esplugues E, et al. Control of TH17 cells occurs in the small intestine. Nature 2011;475:514-518.
96. Srinivas S, et al. Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev Biol 2001;1:4.
97. Premsrirut PK, et al. A rapid and scalable system for studying gene function in mice using conditional RNA interference. Cell 2011;145:145-158.
98. Hochedlinger K, Yamada Y, Beard C, Jaenisch R. Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell 2005;121:465-477.
99. Kleinhammer A, Wurst W, Kuhn R. Constitutive and conditional RNAi transgenesis in mice. Methods 2011;53:430-436.
100. Chandler J, Hohenstein P, Swing DA, Tessarollo L, Sharan SK. Human BRCA1 gene rescues the embryonic lethality of Brca1 mutant mice. Genesis 2001;29:72-77.
101. Swaminathan S, et al. Rapid engineering of bacterial artificial chromosomes using oligonucleotides. Genesis 2001;29:14-21.
102. Yang Y, Swaminathan S, Martin BK, Sharan SK. Aberrant splicing induced by missense mutations in BRCA1: clues from a humanized mouse model. Hum Mol Genet 2003;12:2121-2131.
103. Li Y, et al. Mutant LRRK2(R1441G) BAC transgenic mice recapitulate cardinal features of Parkinson's disease. Nat Neurosci 2009;12:826-828.
104. Weiner HL. The challenge of multiple sclerosis: how do we cure a chronic heterogeneous disease? Ann Neurol 2009;65:239-248.
105. Copeland NG, Jenkins NA, Court DL. Recombineering: a powerful new tool for mouse functional genomics. Nat Rev Genet 2001;2:769-779.
106. Brown WR, Lee NC, Xu Z, Smith MC. Serine recombinases as tools for genome engineering. Methods 2011;53:372-379.